TrialLancet (London, England)2018

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.

Martin R Gaudinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.